- Index
- 1 NOTE F1 Revenue and segment information
- 2 NOTE F2 Consolidated income statement by nature
- 3 NOTE F3 Revenue from non-core activities
- 4 NOTE F4 Other operating gains and losses
- 5 NOTE F5 Results from portfolio management and reassessments, legacy remediation and major litigations
- 6 NOTE F6 Net financial charges
- 7 NOTE F7 Income taxes
- 8 NOTE F8 Discontinued operations
- 9 NOTE F9 Profit for the year
- 10 NOTE F10 Earnings per share
In € million |
2019 |
2018 |
Start-up and preliminary study costs |
(15) |
(11) |
Capital gains/losses on sales of property, plant and equipment and intangible assets |
11 |
22 |
Net foreign exchange gains and losses |
|
(4) |
Amortization of intangible assets resulting from PPA |
(182) |
(197) |
Cytec post-retirement medical obligations reduction |
|
24 |
Other |
55 |
43 |
Other operating gains and losses |
(131) |
(123) |